Objective To analyze the clinical features,risk factors and etiological conditions of pulmonary fungal infection in patients with severe pulmonary infections. Methods A retrospective analysis was performed on 182 critically patients with severe pulmonary infections who met the inclusion criteria in the department of respiratory and critical care medicine of affiliated hospital of Inner Mongolia Medical University from January 2019 to December 2023, including 90 patients with pulmonary fungal infection (confirmed and clinically diagnosed) and 92 patients in a control group. General data,clinical features,imaging changes, etiological data of the patients were summarized and analyzed,and risk factors affecting pulmonary fungal infection were analyzed by Logistic multivariate regression. Results (1)The clinical manifestations of severe patients after fungal infection were mainly cough, sputum, dyspnea, fever, pulmonary rales, and hemoptysis, which were not significantly different from those of the control group.(2) The specimen sources were as follows. Two confirmed patients were diagnosed by bronchoscopic biopsy. Of the 88 clinically diagnosed cases, 65 cases were detected by sputum culture,12 by bronchoalveolar lavage fluid culture, and 11 by sputum culture combined with blood G test and GM test. Among the infected patients. Among the infected patients, 83 cases (92.2%) were detected with one kind of fungus, among which candida albicans was the most detected, followed by Aspergillus,and 7 cases (7.8%) were infected with two kinds of fungi. (3) Multivariate Logistic analysis showed that chronic obstructive pulmonary disease, mechanical ventilation, central venous catheter, duration of glucocorticoid use, duration of broad-spectrum antibiotic use,and hypoproteinemia were independent risk factors for pulmonary fungal infection. (4) ROC curve analysis showed that the AUC value of chronic obstructive pulmonary disease, mechanical ventilation, central venous catheter, duration of glucocorticoid use, duration of broad-spectrum antibiotic use and hypoproteinemia combined to predict pulmonary fungal infection was 0.92, which had a good predictive value. Conclusions Chronic obstructive pulmonary disease, central venous catheter, mechanical ventilation, duration of glucocorticoid use, duration of broad-spectrum antibiotic use and hypoproteinemia are independent risk factors for pulmonary fungal infection in patients with severe pulmonary infections,and the combined value of all the factors is better in predicting the pulmonary fungal infection.
Key words
severe pulmonary infections /
pulmonary fungal infection /
influencing factor /
clinical feature /
pathogenic bacteria
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 杨晓赞,王丽辉,彭丽萍,等.老年2型糖尿病合并侵袭性肺真菌病的研究进展[J].中国老年学杂志,2023,43(16):4087-4092.
[2] Verweij P E, Rijnders B J A, Brüggemann R J M , et al.Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion[J].Intensive Care Med,2020,46(8):1524-1535.
[3] 中华医学会呼吸病学分会感染学组,中华结核和呼吸杂志编辑委员会.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-834.
[4] 周娜娜. 动态评估血清降钙素原及肺部感染评分对指导重症肺炎合理应用抗生素的临床价值[J].吉林医学,2024,45(8):1838-1842.
[5] 刘辉,敬碧珍,尹欢等.慢性阻塞性肺疾病急性加重期患者继发肺部真菌感染的影响因素分析[J].解放军医药杂志,2021,33(3):68-71.
[6] 朱广发. 侵袭性肺真菌病诊治指南解析[J]. 心肺血管病杂志, 2012, 31(2):137-140
[7] Zhou B,She J,Yang L, et al.Coexistent pulmonary cryptococcal infection and pulmonary sarcoidosis: a case report and literature review[J].J Int Med Res,2020,48(2):0300060520903870.
[8] 彭晓露. 重症肺炎发生肺部真菌感染的危险因素及预后分析[D].重庆:重庆医科大学,2023.
[9] Pfaller M A,Diekema D J.Epidemiology of invasive candidiasis: a persistent public health problem.[J].Clin Microbiol Rev,2007,20(1):133-163.
[10] 廖建丰,黄若新,谢其华,慢性阻塞性肺疾病合并糖尿病患者肺部真菌感染的病原学及易感因素分析[J]实用临床医药杂志,2016,20(23):152-153.
[11] Ortega M, Marco F, Sórano A, et al. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008[J]. J Hosp Infect, 2011,77(2): 157-161.
[12] 李悦闻. 血液病患者念珠菌血流感染的临床分析[D].河北:河北医科大学,2020.
[13] 郭婧,黄雅轩,张莉滟,等.ICU假丝酵母血流感染患者临床特征及预后危险因素[J].中华医院感染学杂志,2024,34(17):2589-2593.
[14] 靳妍玉,任冬梅,韩李周,等.下呼吸道感染患者支气管肺泡灌洗液病原菌分布及耐药性分析[J].医药论坛杂志,2022,43(11):54-57.
[15] 孙焕影. 肺部真菌感染的临床分析[D].河北:河北医科大学,2022.
[16] 申沪,吴洪波,曹煜.老年慢性阻塞性肺疾病急性加重期患者并发肺部真菌感染的相关因素[J].中国老年学杂志,2023,43(19):4687-4690.
[17] 杜伟伟,季文涛,罗甜,等.肺癌患者合并肺部真菌感染的风险预测模型[J].中山大学学报(医学科学版),2023,44(6):1022-1029.
[18] 郑迈克,郭艳玲,马尚,等.肺癌患者合并肺部真菌感染的危险因素及其耐药性的Meta分析[J].中华医院感染学杂志,2024,34(4):531-537.
[19] 何方,曹大伟,刘超峰,等.呼吸内科肺部真菌感染危险因素分析[J].山西医科大学学报,2016,47(2):142-145.